PHAXIAM Therapeutics S.A. Current Liabilities
PHAXIAM Therapeutics S.A. had Current Liabilities of EUR 17.39 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:CurrentLiabilities · last filed 2023-09-26
- 2023-06-30: Current Liabilities 17.39M EUR.
- 2022-12-31: Current Liabilities 11.68M EUR.
- 2022-06-30: Current Liabilities 27.56M EUR.
- 2021-12-31: Current Liabilities 20.00M EUR.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2023-06-30 | 17.39M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 11.68M EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 27.56M EUR 6-K · filed 2022-09-12 | |
| 2021-12-31 | 20.00M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 23.43M EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 29.35M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 22.59M EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | 19.88M EUR 20-F · filed 2022-04-27 | 19.88M EUR 20-F · filed 2020-03-18 |
| 2019-06-30 | 18.66M EUR 6-K · filed 2019-09-26 | |
| 2018-12-31 | 20.65M EUR 20-F · filed 2021-03-08 | 20.65M EUR 20-F · filed 2019-03-29 |
| 2017-12-31 | 11.61M EUR 20-F · filed 2020-03-18 | |
| 2016-12-31 | 6.35M EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | 5.62M EUR 20-F/A · filed 2018-05-23 |